Bristol-Myers trims more jobs in NJ

Pharmalot reports today that Bristol-Myers Squibb ($BMY) is trimming another 100 or so jobs from the payroll. These latest cuts follow a move to eliminate 479 jobs, mostly in sales. These new cuts are falling across a number of departments, including  "sales, medical support and data analytics specialists." About half of these positions are in Plainsboro, NJ, in a state which has suffered a litany of setbacks on the life sciences front. Story

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.